Venture Life Group (VLG) Share Price, News & Analysis

Company Overview

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the global self-care market. With operations in the UK, The Netherlands and Italy, the Group's product portfolio includes some key products such as the UltraDEX and Dentyl oral care product ranges, food supplements for maintaining brain function, medical devices for women's intimate healthcare, fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing. The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples. In the UK and The Netherlands these are supplied direct by the company to retailers, elsewhere they are supplied by the Group's international distribution partners. Through its Development & Manufacturing facilities in Italy & Sweden the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.

Key Stats

• Today's Range: 60.22 to 65.50
• 50-Day Range: 50 to 65.50
• 52-Week Range: 32 to 66
• Volume: 481,033 shs
• Average Volume: 359,404 shs
• Market Capitalization: £83.46 million
• P/E Ratio: 111.15
• Dividend Yield: 0.09%
• Price Target: N/A
• Consensus Rating: N/A

VLG Stock Analysis - Frequently Asked Questions

How have VLG shares performed this year?

Venture Life Group's stock was trading at GBX 39 at the beginning of the year. Since then, VLG shares have increased by 67.9% and is now trading at GBX 65.50.

How were Venture Life Group's earnings last quarter?

Venture Life Group plc (LON:VLG) announced its quarterly earnings results on Monday, June, 30th. The company reported $3.96 earnings per share for the quarter. Venture Life Group had a trailing twelve-month return on equity of 0.99% and a net margin of 1.44%.

How do I buy shares of Venture Life Group?

Shares of VLG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Venture Life Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Venture Life Group investors own include Eagle Point Credit (ECC), Antero Resources (AR), Oxford Lane Capital (OXLC), BATM Advanced Communications (BVC), Kape Technologies (KAPE), Litigation Capital Management (LIT) and Meta Platforms (META).

Company Calendar

• Last Earnings: 6/30/2025
• Today: 8/09/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: LON:VLG
• CIK: N/A
• Web: www.venture-life.com
• Phone: +44-1344-742870
• Fax: N/A
• Employees: 165
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): GBX 0.59
• Trailing P/E Ratio: 111.15
• Forward P/E Ratio: 10.67
• P/E Growth: 5.67
• Net Income: £747.21 thousand
• Net Margins: 1.44%
• Pretax Margin: N/A
• Return on Equity: 0.99%
• Return on Assets: 1.56%

Debt

• Debt-to-Equity Ratio: 28.45
• Current Ratio: 2.22
• Quick Ratio: 1.48

Sales & Book Value

• Annual Sales: £51.77 million
• Price / Sales: 1.61
• Cash Flow: GBX 10.24 per share
• Price / Cash Flow: 6.40
• Book Value: GBX 58.74 per share
• Price / Book: 1.12

Miscellaneous

• Outstanding Shares: 127,425,658
• Free Float: N/A
• Market Cap: £83.46 million
• Optionable: Not Optionable
• Beta: 0.30